Loading...

Talphera, Inc.

TLPHNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.78
$-0.02(-3.00%)
U.S. Market opens in NaNh NaNm

Talphera, Inc. Fundamental Analysis

Talphera, Inc. (TLPH) shows weak financial fundamentals with a PE ratio of -2.28, profit margin of -510.36%, and ROE of -1.18%. The company generates $0.0B in annual revenue with weak year-over-year growth of -1.00%.

Key Strengths

Cash Position62.65%
PEG Ratio-0.07
Current Ratio5.49

Areas of Concern

ROE-1.18%
Operating Margin-481.57%
We analyze TLPH's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -38469.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-38469.0/100

We analyze TLPH's fundamental strength across five key dimensions:

Efficiency Score

Weak

TLPH struggles to generate sufficient returns from assets.

ROA > 10%
-48.08%

Valuation Score

Excellent

TLPH trades at attractive valuation levels.

PE < 25
-2.28
PEG Ratio < 2
-0.07

Growth Score

Moderate

TLPH shows steady but slowing expansion.

Revenue Growth > 5%
-1.00%
EPS Growth > 10%
61.24%

Financial Health Score

Excellent

TLPH maintains a strong and stable balance sheet.

Debt/Equity < 1
0.38
Current Ratio > 1
5.49

Profitability Score

Weak

TLPH struggles to sustain strong margins.

ROE > 15%
-118.01%
Net Margin ≥ 15%
-510.36%
Positive Free Cash Flow
No

Key Financial Metrics

Is TLPH Expensive or Cheap?

P/E Ratio

TLPH trades at -2.28 times earnings. This suggests potential undervaluation.

-2.28

PEG Ratio

When adjusting for growth, TLPH's PEG of -0.07 indicates potential undervaluation.

-0.07

Price to Book

The market values Talphera, Inc. at 1.91 times its book value. This may indicate undervaluation.

1.91

EV/EBITDA

Enterprise value stands at -1.33 times EBITDA. This is generally considered low.

-1.33

How Well Does TLPH Make Money?

Net Profit Margin

For every $100 in sales, Talphera, Inc. keeps $-510.36 as profit after all expenses.

-510.36%

Operating Margin

Core operations generate -481.57 in profit for every $100 in revenue, before interest and taxes.

-481.57%

ROE

Management delivers $-1.18 in profit for every $100 of shareholder equity.

-1.18%

ROA

Talphera, Inc. generates $-48.08 in profit for every $100 in assets, demonstrating efficient asset deployment.

-48.08%

Following the Money - Real Cash Generation

Operating Cash Flow

Talphera, Inc. generates limited operating cash flow of $-5.50M, signaling weaker underlying cash strength.

$-5.50M

Free Cash Flow

Talphera, Inc. generates weak or negative free cash flow of $-5.50M, restricting financial flexibility.

$-5.50M

FCF Per Share

Each share generates $-0.27 in free cash annually.

$-0.27

FCF Yield

TLPH converts -71.44% of its market value into free cash.

-71.44%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.28

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.91

vs 25 benchmark

P/S Ratio

Price to sales ratio

562.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.38

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.49

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.18

vs 25 benchmark

ROA

Return on assets percentage

-0.48

vs 25 benchmark

ROCE

Return on capital employed

-0.52

vs 25 benchmark

How TLPH Stacks Against Its Sector Peers

MetricTLPH ValueSector AveragePerformance
P/E Ratio-2.2828.81 Better (Cheaper)
ROE-118.01%643.00% Weak
Net Margin-51035.71%-44312.00% (disorted) Weak
Debt/Equity0.380.36 Neutral
Current Ratio5.494.50 Strong Liquidity
ROA-48.08%-17799.00% (disorted) Weak

TLPH outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Talphera, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-100.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

96.26%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

96.20%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ